What is Jakavi:
Jakavi (ruxolitinib) is the first and only FDA-approved treatment for patients with polycythemia vera (PV) who have had an inadequate response to or are intolerant of hydroxyurea1. Ruxolitinib (trade name Jakavi) is a drug for the treatment of intermediate or high-risk myelofibrosis, a type of myeloproliferative disorder that affects the bone marrow, and for polycythemia vera (PCV) when there has been an inadequate response to or intolerance of hydroxyurea.
1. Brand Name - Jakavi
2. Generic - Ruxolitinib
3. Strength - 5 Mg, 15 Mg and 20 Mg
4. Form - Tablets
5. Packing - 56 Tablets
6. Manufactured by - Novartis
Side effects of Jakavi:
Some side effects of Jakafi may be related to the symptoms of myelofibrosis. talk to your doctor if you have serious side effects of Jakafi including:• pale skin,
• shortness of breath,
• rapid heart rate,
• trouble concentrating,
• easy bruising,
• unusual bleeding (nose, mouth, vagina, or rectum),
• purple or red pinpoint spots under your skin,
Uses of Jakavi:Take this medicine by mouth with a glass of water. Do not take with grapefruit juice. Follow the directions on the prescription label. Take your medicine at regular intervals. What doctor suggests to you to take it only have enough? Always follow your doctor don’t stop takingthis drug except on your doctor's advice. Talk to your paediatrician related the use of this medicine for children. Special care may be needed.
Modern Times Helpline Pharma, we are a leading Suppliers, Dealers, Exporters and giving best Price on Hepatitis C, Anti-cancer medicines and HIV medicine, you can buy all these medicine by giving online order, simply fill the contact form We will within 24 hours !